Solid Biosciences (SLDB) Tops Q4 EPS by 17c

Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming